SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aronex Pharma (ARNX) -- Ignore unavailable to you. Want to Upgrade?


To: Dexter Enders who wrote (151)9/21/1998 1:42:00 PM
From: Sam Lee  Read Replies (1) | Respond to of 320
 
Atragen has produced total remission in most patients with acute promyelocytic leukemia (APL) and there is some indication,so I have heard, that it may be effective against more general forms of leukemia. However,that has not been proven. It is something I picked up 3rd hand from a private investment advisor who follows the company.